Ilex Medical (TA:ILX) — Market Cap & Net Worth
Market Cap & Net Worth: Ilex Medical (ILX)
Ilex Medical (TA:ILX) has a market capitalization of $147.73 Million (ILA55.10 Billion) as of July 24, 2026. Listed on the TA stock exchange, this Israel-based company holds position #17690 globally and #225 in its home market, demonstrating a -1.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ilex Medical's stock price ILA4925.00 by its total outstanding shares 11188107 (11.19 Million). See Ilex Medical capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Ilex Medical Market Cap History: 2015 to 2026
Ilex Medical's market capitalization history from 2015 to 2026. Data shows growth from $80.69 Million to $147.73 Million (5.50% CAGR).
Ilex Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ilex Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.24x
Ilex Medical's market cap is 0.24 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.76x
Ilex Medical's market cap is 5.76 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $80.69 Million | $497.50 Million | $31.11 Million | 0.16x | 2.59x |
| 2016 | $99.24 Million | $518.94 Million | $27.65 Million | 0.19x | 3.59x |
| 2017 | $130.35 Million | $553.66 Million | $37.40 Million | 0.24x | 3.48x |
| 2018 | $132.47 Million | $601.13 Million | $46.98 Million | 0.22x | 2.82x |
| 2019 | $218.90 Million | $633.96 Million | $60.26 Million | 0.35x | 3.63x |
| 2020 | $323.22 Million | $946.45 Million | $120.62 Million | 0.34x | 2.68x |
| 2021 | $449.92 Million | $1.06 Billion | $197.48 Million | 0.42x | 2.28x |
| 2022 | $274.98 Million | $872.54 Million | $102.12 Million | 0.32x | 2.69x |
| 2023 | $172.73 Million | $916.25 Million | $50.88 Million | 0.19x | 3.39x |
| 2024 | $224.66 Million | $920.37 Million | $38.98 Million | 0.24x | 5.76x |
Competitor Companies of ILX by Market Capitalization
Companies near Ilex Medical in the global market cap rankings as of July 24, 2026.
Key companies related to Ilex Medical by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #128 globally with a market cap of $175.19 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #192 globally with a market cap of $122.07 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #240 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #128 | Abbott Laboratories | NYSE:ABT | $175.19 Billion | $100.75 |
| #192 | Stryker Corporation | NYSE:SYK | $122.07 Billion | $318.97 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $82.01 |
Ilex Medical Historical Marketcap From 2015 to 2026
Between 2015 and today, Ilex Medical's market cap moved from $80.69 Million to $ 147.73 Million, with a yearly change of 5.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA147.73 Million | -25.94% |
| 2025 | ILA199.47 Million | -11.21% |
| 2024 | ILA224.66 Million | +30.06% |
| 2023 | ILA172.73 Million | -37.18% |
| 2022 | ILA274.98 Million | -38.88% |
| 2021 | ILA449.92 Million | +39.20% |
| 2020 | ILA323.22 Million | +47.66% |
| 2019 | ILA218.90 Million | +65.24% |
| 2018 | ILA132.47 Million | +1.63% |
| 2017 | ILA130.35 Million | +31.34% |
| 2016 | ILA99.24 Million | +22.99% |
| 2015 | ILA80.69 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 24th, 2026 the market cap of Ilex Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $147.73 Million USD |
| MoneyControl | $147.73 Million USD |
| MarketWatch | $147.73 Million USD |
| marketcap.company | $147.73 Million USD |
| Reuters | $147.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ilex Medical
Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine micros… Read more